02 November 2021>: Clinical Research
Outcomes from the Use of Perioperative Extracorporeal Membrane Oxygenation in Patients Undergoing Thoracic Surgery: An 8-Year Single-Center Experience
Weizhao Huang 1ABDEF , Hongyu Ye 1ACF , Zhou Cheng 2AF , Xiaozu Liao 2BF , Liqiang Wang 2BCD , Binfei Li 2CDF , Yi Liang 1DFG* , Haiming Jiang 1DEFGDOI: 10.12659/MSM.931842
Med Sci Monit 2021; 27:e931842
Table 2 Survival rate according to timing and mode of extracorporeal membrane oxygenation.
Factors | Case | Survived | P-value | |
---|---|---|---|---|
Yes | No | |||
Timing | 0.135 | |||
Preoperative | 12 | 11 | 1 | |
Postoperative | 10 | 6 | 4 | |
Mode | 0.550 | |||
V-V ECMO | 13 | 11 | 2 | |
V-A ECMO | 9 | 7 | 2 | |
V-V ECMO – veno-venous extracorporeal membrane oxygenation; V-A ECMO – veno-arterial extracorporeal membrane oxygenation. |